Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
4.355
-0.195 (-4.29%)
Mar 31, 2025, 10:53 AM EDT - Market open
Health Catalyst Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 9.27, with a low estimate of 5.00 and a high estimate of 16. The average target predicts an increase of 112.86% from the current stock price of 4.36.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 2 |
| Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Hold | 4 | 3 | 3 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +14.81% | Mar 6, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +37.77% | Feb 27, 2025 |
| Stifel | Stifel | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | +14.81% | Feb 27, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +60.73% | Feb 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +83.70% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
341.31M
from 306.58M
Increased by 11.33%
Revenue Next Year
374.34M
from 341.31M
Increased by 9.68%
EPS This Year
0.29
from -1.15
EPS Next Year
0.43
from 0.29
Increased by 45.26%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 352.1M | 398.0M | 433.2M | |
| Avg | 341.3M | 374.3M | 410.7M | |
| Low | 324.3M | 345.6M | 388.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.8% | 16.6% | 15.7% | |
| Avg | 11.3% | 9.7% | 9.7% | |
| Low | 5.8% | 1.2% | 3.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.47 | 0.68 | 1.00 | |
| Avg | 0.29 | 0.43 | 0.74 | |
| Low | 0.21 | 0.32 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 130.2% | 133.0% | |
| Avg | - | 45.3% | 72.5% | |
| Low | - | 9.7% | 32.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.